Publication|Articles|March 19, 2026
- Pharmaceutical Executive: March 2026
- Volume 46
- Issue 2
Pharmaceutical Executive: March 2026 Interactive Digital Edition
View the Pharmaceutical Executive March 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
about 1 month ago
Data and Trustabout 2 months ago
Andrew Hall: The Discipline of Convictionabout 2 months ago
Agentic AI and the Future of Commercial Excellence in Life Sciencesabout 2 months ago
Cautious Momentum: Biopharma Review and Outlookabout 2 months ago
Orphan Product Risk Contractingabout 2 months ago
JCA vs. Reality: Europe’s Push for Clinical Harmonizationabout 2 months ago
AI has Redefined Healthcare Communication — and There’s No Opting Outabout 2 months ago
Consent‑Driven Targeting: Building Trust With Patients and HCPsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
What Impact Could Recent US Regulatory Actions Have on Global Pricing and Launches?
2
Why Ireland Has Become a Strategic Hub for the Global Pharmaceutical Industry
3
Pharma M&A Roundup: IMG Pharma Acquires Matsumoto Pharmaceutical, Sun Pharma Acquires Organon
4
FDA Approves Breztri for Patients 12 Years and Older with Asthma
5
